• No results found

University of Groningen Imaging hormone receptors in metastatic breast cancer patients Venema, Clasina Marieke

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Imaging hormone receptors in metastatic breast cancer patients Venema, Clasina Marieke"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Imaging hormone receptors in metastatic breast cancer patients Venema, Clasina Marieke

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Venema, C. M. (2018). Imaging hormone receptors in metastatic breast cancer patients. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema Processed on: 7-3-2018 Processed on: 7-3-2018 Processed on: 7-3-2018

Processed on: 7-3-2018 PDF page: 1PDF page: 1PDF page: 1PDF page: 1

Imaging hormone receptors in metastatic breast cancer patients

(3)

517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema Processed on: 7-3-2018 Processed on: 7-3-2018 Processed on: 7-3-2018

Processed on: 7-3-2018 PDF page: 2PDF page: 2PDF page: 2PDF page: 2

Venema CM,

Molecular imaging of hormone receptors in metastatic breast cancer patients

Thesis, University of Groningen, The Netherlands

ISBN: 978-94-028-0983-1 Printing: Ipskamp

The printing of this thesis was financially supported by Graduate School of Medical Sciences and Stichting Werkgroep Interne Oncologie, the Faculty of Medical Sciences, University of Groningen, and is gratefully acknowledged.

(4)

517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema Processed on: 7-3-2018 Processed on: 7-3-2018 Processed on: 7-3-2018

Processed on: 7-3-2018 PDF page: 3PDF page: 3PDF page: 3PDF page: 3

Imaging hormone receptors

in metastatic breast cancer

patients

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken

en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op

woensdag 9 mei 2018 om 16.15 uur

door

Clasina Marieke Venema

geboren op 10 november 1988 te Alkmaar

(5)

517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema Processed on: 7-3-2018 Processed on: 7-3-2018 Processed on: 7-3-2018

Processed on: 7-3-2018 PDF page: 4PDF page: 4PDF page: 4PDF page: 4

Promotor

Prof. G.A.P. Hospers Copromotores C.P. Schroder E.F.J. de Vries

A.W.J.M. Glaudemans Beoordelingscommissie Prof. I.J. de Jong

Prof. R.H.J.A. Slart Prof. S. Sleijfer

(6)

517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema Processed on: 7-3-2018 Processed on: 7-3-2018 Processed on: 7-3-2018

Processed on: 7-3-2018 PDF page: 5PDF page: 5PDF page: 5PDF page: 5

Paranimfen

Kirsten Moek Luuk Römers

(7)

517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema Processed on: 7-3-2018 Processed on: 7-3-2018 Processed on: 7-3-2018

Processed on: 7-3-2018 PDF page: 6PDF page: 6PDF page: 6PDF page: 6

CONTENTS Introduction

Chapter 1 General introduction and outline of the thesis

The estrogen receptor and molecular imaging

Chapter 2 Recommendations and technical aspects of 16α-18 F-fluoro-17β-estradiol (FES) PET to image the estrogen receptor in vivo: the Groningen experience. Clin Nucl Med 2016; 41:844-851

Chapter 3 Interpretation of pulmonary uptake on FES PET scans after radiation therapy of the thorax

Chapter 4 18F-fluoroestradiol positron emission tomography (FES PET) has added value in staging and therapy decision making in patients with disseminated lobular breast cancer. Clin Nucl Med 2017; 42:612-614

Chapter 5 Early identification of patients who benefit from palbociclib in addition to letrozole: a new role for FES PET

The androgen receptor and molecular imaging

Chapter 6 Targeting the androgen receptor: a potentially more valuable therapeutic strategy in breast cancer when additional tumour characteristics are taken into account

Chapter 7 Androgen and estrogen receptor imaging in metastatic breast cancer patients as a surrogate for tissue biopsies. J Nucl Med 2017; 58: 1906-1912

Chapter 8 Visualizing the effects of bicalutamide on the androgen receptor availability in metastatic breast cancer patients

(8)

517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema Processed on: 7-3-2018 Processed on: 7-3-2018 Processed on: 7-3-2018

Processed on: 7-3-2018 PDF page: 7PDF page: 7PDF page: 7PDF page: 7

Future perspectives

Chapter 9 Translation of new molecular imaging approaches to the clinic- bridging the gap to implementation. J Nucl Med 2016:57: suppl 1: 96S-104S

Chapter 10 Summary and future perspectives

Chapter 11 Nederlandse samenvatting (Dutch summary)

(9)

517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema 517613-L-sub01-bw-Venema Processed on: 7-3-2018 Processed on: 7-3-2018 Processed on: 7-3-2018

Referenties

GERELATEERDE DOCUMENTEN

11 The purpose of our study therefore was to evaluate whether FDHT PET imaging in metastatic breast cancer can be used to predict early treatment response to bicalutamide.. Not

In ER- positive breast cancer patients that have high risk to develop metastases or have clinical signs, laboratory values or histology suggestive of the presence of

As this enhanced uptake was seen in the lungs and most patients were irradiated in the thoracic area, we hypothesized that pulmonary fibrosis as a result of earlier radiation

Because of the discrepancy between the different conventional imaging modalities, a FES-PET was performed, which showed high tracer uptake in multiple bone lesions and lymph

In this feasibility study, we investigated on a lesion by lesion basis whether non-invasive in vivo imaging of ER expression in metastatic breast cancer patients by means of

Overall survival rate (y-axis) in years (x-axis) according to mRNA profiling for oestrogen receptor (ER), androgen receptor (AR) and human epidermal growth factor receptor 2

Secondary endpoints were the optimum threshold to discriminate positive and negative lesions for both AR and ER on PET, inter- and intra-patient FDHT and FES heterogeneity, and

In case of non- measurable, bone only disease, imaging was performed according to the physicians’ choice and a deterioration of symptoms (such as pain or increased fatigue)